DEA Adds More Benzimidazole-Opioids to Schedule I Drug List
The Drug Enforcement Administration is permanently placing the synthetic benzimidazole-opioids butonitazene, flunitazene and metodesnitazene in Schedule I of the Controlled Substances Act, it said in a final rule. The substances had already been temporarily listed in Schedule I since 2022…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(see 2204110029). The final rule takes effect Oct. 25.